SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001279569-15-001056
Filing Date
2015-05-14
Accepted
2015-05-13 18:56:18
Documents
7
Period of Report
2015-05-13

Document Format Files

Seq Description Document Type Size
1 FORM 6-K v410524_6k.htm 6-K 17300
2 EXHIBIT 99.1 v410524_ex99-1.htm EX-99.1 118341
3 EXHIBIT 99.2 v410524_ex99-2.htm EX-99.2 222478
4 EXHIBIT 99.3 v410524_ex99-3.htm EX-99.3 111868
5 EXHIBIT 99.4 v410524_ex99-4.htm EX-99.4 14319
6 EXHIBIT 99.5 v410524_ex99-5.htm EX-99.5 13820
7 GRAPHIC image_001.jpg GRAPHIC 5015
  Complete submission text file 0001279569-15-001056.txt   506297
Mailing Address 6TH FLOOR 1441 CREEKSIDE DRIVE VANCOUVER A1 V6J 4S7
Business Address 6TH FLOOR 1441 CREEKSIDE DRIVE VANCOUVER A1 V6J 4S7 1-604-677-6905
Cardiome Pharma Corp (Filer) CIK: 0001036141 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-29338 | Film No.: 15859801
SIC: 2834 Pharmaceutical Preparations